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Summ a r y
Integrin α3 is a transmembrane integrin receptor subunit that mediates signals 
between the cells and their microenvironment. We identified three patients with 
homozygous mutations in the integrin α3 gene that were associated with disrupted 
basement-membrane structures and compromised barrier functions in kidney, lung, 
and skin. The patients had a multiorgan disorder that included congenital nephrotic 
syndrome, interstitial lung disease, and epidermolysis bullosa. The renal and respira-
tory features predominated, and the lung involvement accounted for the lethal course 
of the disease. Although skin fragility was mild, it provided clues to the diagnosis.
Epithelial–mesenchymal interactions are important in the de-velopment and tissue homeostasis of many multicompartment organs, such as the kidneys, lungs, and skin.1 Adhesion of epithelial cells to basement 
membranes provides the structural and functional integrity of the organs. Cues 
from the extracellular environment that are transduced to the cell and vice versa 
regulate adhesion, which is partially dependent on integrins.2 Mutations in integrin 
genes are associated with various human disorders, including epidermolysis bullosa 
with pyloric atresia, congenital muscular dystrophy, leukocyte adhesion deficiency, 
and Glanzmann’s thrombasthenia.3,4 Integrin α3, which forms heterodimers with 
integrin β1, is widely expressed in both fetal and adult tissues5 and has complex 
functions, as shown in mouse models and in vitro studies.6-17
Here we report on three infants with congenital nephrotic syndrome, interstitial 
lung disease, and skin fragility who were homozygous for mutations in the integrin 
α3 gene (ITGA3). Although the renal and respiratory features predominated clinically, 
it was the investigation of the skin fragility that first suggested the molecular defect.
C a se R eport s
Patient 1 was the index patient in whom the genetic defect was discovered and the 
complex phenotype was characterized. Subsequently, two other infants, Patients 2 and 
3, were found to have similar clinical features and ITGA3 mutations (Table 1 in the 
Supplementary Appendix, available with the full text of this article at NEJM.org).
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Patient 1 was a boy born to a 41-year-old moth-
er (gravida 2, para 2) at a gestation of 41 weeks 
4 days, after an uneventful pregnancy. The parents 
were reportedly unrelated, and the family history 
was unremarkable, with no history of renal dis-
ease. The mother’s kidney function was normal at 
the time of delivery. Labor was induced because of 
fetal postmaturity and oligohydramnios. Immedi-
ately after birth, severe tachypnea and respiratory 
distress requiring high-flow supplemental oxygen 
developed in the infant. On the first day of life, 
chest radiography showed severe reticulonodular 
changes (Fig. 1A). On day 13, laboratory investiga-
tions revealed renal failure (glomerular filtration 
rate [GFR], <10 ml per minute per 1.73 m2 of body-
surface area) and the nephrotic syndrome (ratio of 
urinary protein to creatinine, 12.5) (Table 2 in the 
Supplementary Appendix), and peritoneal dialy-
sis was initiated on day 14. Abdominal ultraso-
nography showed small, hyperechoic kidneys (Fig. 
1B). Respiratory distress persisted, and recurrent 
vomiting episodes with secondary aspiration as-
sociated with life-threatening events and respira-
tory tract infections complicated the course. High-
resolution computed tomography (CT) of the chest 
showed nonspecific diffuse distortion of the pul-
monary architecture (Fig. 1C). From the age of 3 
months, the infant had increasing skin fragility, 
with small blisters and erosions after mechanical 
manipulation. The lesions healed slowly, without 
scarring but with residual erythema (Fig. 1D 
and 1E). There was no mucosal involvement. The 
scalp hair, eyebrows, and eyelashes were fine and 
sparse (Fig. 1F). The big toenails became dystro-
phic (Fig. 1G), and distal onycholysis followed mild 
trauma to the fingernails.
At 1 month of age, a renal specimen obtained 
by percutaneous needle biopsy with ultrasono-
graphic guidance revealed globally atrophic glom-
eruli, focal segmental glomerulosclerosis, diffuse 
interstitial fibrosis, tubular atrophy, and loss and 
immaturity of the tubules (Fig. 1H). At the age of 
5.5 months, a lung specimen obtained by open 
biopsy from the middle lobe, which was markedly 
abnormal on CT, showed hyperinflation and mild-
to-moderate simplification of air spaces, suggest-
ing impaired alveolarization or lobular remodeling 
(Fig. 1I). Mild reactive changes in the bronchioles 
included intraluminal mucus stasis, focal neutro-
phils, and focal bronchiolar fibrosis. (For a de-
scription of other clinical features and investiga-
tions, see Tables 1 and 2 in the Supplementary 
Appendix.) The infant died at the age of 7.5 months 
during an episode of pulmonary infection.
Patient 2, a girl born to healthy consanguine-
ous parents, was the only affected child among 
nine siblings. Two days after delivery, respiratory 
distress and episodes of cyanosis developed. At 
the age of 6 weeks, chest radiography showed 
bilateral infiltrates, and the findings on chest CT 
were consistent with diffuse interstitial lung dis-
ease (Fig. 1 in the Supplementary Appendix). Labo-
ratory tests at 6 weeks of age indicated proteinuria 
in the nephrotic range, and peritoneal dialysis 
was initiated. In spite of intensive care, the child 
died from multiorgan failure at 2 months of age.
Patient 3, a girl born at term, was the first child 
of healthy consanguineous parents. At 2 months of 
age, fever and respiratory distress developed. The 
findings on chest radiography were consistent with 
pneumonia in the right upper and middle lobes, 
which was considered to be due to aspiration. Pro-
teinuria in the nephrotic range was noted, and a 
renal-biopsy specimen obtained at 5 months of age 
showed focal segmental glomerulosclerosis. Renal 
function deteriorated progressively and necessi-
tated peritoneal dialysis at 17 months of age, al-
though control of the edema was unsuccessful, 
even while the infant was receiving dialysis. She 
continued to have recurrent respiratory infections 
and required supplemental oxygen to maintain 
peripheral oxygen saturation values at a level above 
90%. At 4 months, annular erythematous lesions 
were noted on the infant’s shins; these later devel-
oped into blisters that were consistent with epider-
molysis bullosa. She died at the age of 19 months 
from multiorgan failure related to infection.
Me thods
Genetic Analyses
After the infants’ parents had provided written 
informed consent, EDTA-treated blood samples 
were obtained from the three patients and their 
parents. Genomic DNA was extracted from pe-
ripheral-blood leukocytes, and the coding region 
and exon–intron boundaries of ITGA3, as well as 
other candidate genes, were analyzed (see the 
Methods section and Table 3 in the Supplemen-
tary Appendix).
Morphologic Analyses
Tissue samples were studied with conventional 
light microscopy, transmission electron microsco-
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py, immunohistochemical analysis, and fluores-
cence microscopy (see the Methods section and 
Table 4 in the Supplementary Appendix).
In Vitro Studies of Keratinocytes
Primary keratinocytes from Patient 1 were used to 
assess integrin α3 in vitro. The cells were isolated 
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Figure 1. Clinical and Morphologic Features of Patient 1.
Panel A shows a chest radiograph obtained on the first day of life. Panel B shows the results of neonatal ultrasonog-
raphy, revealing bilateral, orthotopic small kidneys with hyperechogenic parenchyma, without corticomedullary dif-
ferentiation, suggesting renal dysplasia. Panel C shows a computed tomographic scan of the chest obtained at the 
age of 4 months, revealing diffuse distortion of the pulmonary architecture, coarsened interstitial changes in the 
lung with thickened interlobular and intralobular septa in all segments; other images showed consolidation in the 
right posterior upper lobe. Panels D and E show progressive skin blisters and erosions on the leg (arrows), with an 
interval of 30 days between the two photographs. The arrowhead indicates the biopsy site. Panel F shows very fine, 
sparse scalp and eyebrow hair, and Panel G shows a dystrophic toenail. Panel H shows kidney-biopsy samples ob-
tained from a control subject and Patient 1, revealing atrophic glomeruli, single collapsed loops, segmental sclero-
sis, occasionally fibrous obliteration of Bowman’s capsule space, and focal tubular atrophy in the patient. Diffuse in-
terstitial fibrosis is associated with lymphocytic infiltrates. Panel I shows lung-biopsy specimens obtained from a 
control subject and Patient 1, revealing well-expanded lung parenchyma with irregular air-space expansion, areas of al-
veolar duct distention, and zones of mild-to-moderate peripheral air-space distention and simplification, with intact 
respiratory epithelium, in the patient (hematoxylin and eosin staining in Panels H and I).
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from skin samples obtained from a control sub-
ject and the patient, expanded in culture, and sub-
mitted to flow cytometry (see the Methods sec-
tion in the Supplementary Appendix).
R esult s
Morphologic Analyses of Skin and ITGA3 
Mutations 
In Patient 1, a candidate-gene approach led to iden-
tification of the genetic defect. We first ruled out 
mutations in NPHS2 and WT1, which are known to 
cause congenital nephrotic syndrome.18 The most 
frequent mutations in CFTR and ABCA3 were ruled 
out as a cause of the interstitial lung disease.19
Morphologic analyses of skin samples were 
performed in order to classify the subtype of epi-
dermolysis bullosa. Light microscopy showed a flat 
epidermis without rete ridges, and subepidermal 
blisters were evident (Fig. 2A in the Supplemen-
tary Appendix). Transmission electron microsco-
py revealed pronounced abnormalities of the base-
ment membrane, with a thin lamina densa, 
discontinuous between the hemidesmosomes (Fig. 
2B in the Supplementary Appendix). In contrast, 
keratin filaments, desmosomes, hemidesmosomes, 
and anchoring fibrils appeared to be normal. In 
blistered areas, the lamina densa was located at 
the blister floor, and occasionally, intact hemides-
mosomes and cell fragments adhered to it, indi-
cating multiple split levels. Immunofluorescence 
mapping revealed focal disruption of the dermal–
epidermal junction with cleavage within the base-
ment membrane. These abnormalities did not 
correspond to any known type of epidermolysis 
bullosa in humans20 but had striking similari-
ties to the findings described in the integrin α3 
knockout mouse.14
The lack of integrin α3 immunoreactivity in the 
skin of Patient 1 was the pivotal diagnostic fea-
ture, which suggested loss of this protein (Fig. 2A). 
Direct sequencing of the patient’s DNA disclosed 
the homozygous mutation c.1173_1174del in exon 
8 in ITGA3 (Fig. 2B). Both parents were unaffect-
ed, heterozygous carriers of this mutation, which 
is predicted to lead to a frameshift starting with 
codon 392 and to premature termination of trans-
lation two codons downstream, p.Pro392ValfsX2.
Given our findings in Patient 1, we screened 
eight patients with congenital nephrotic syndrome 
and homozygosity at the ITGA3 locus for muta-
tions. Patients 2 and 3 were found to be homo-
zygous for the ITGA3 mutations c.1538-1G→A, in 
intron 11, and c.1883G→C, p.Arg628Pro, in exon 
14, respectively (Fig. 3 in the Supplementary Ap-
pendix). The mutation c.1538-1G→A is predicted 
to abolish the splice acceptor site of exon 12, ac-
cording to a database with predictions of splice 
sites (www.cbs.dtu.dk/services/NetGene2). Conse-
quently, exon 12 could be skipped, leading to 
frameshift and a premature stop codon. The mis-
sense mutation found in Patient 3 replaces a con-
served, positively charged arginine with a neutral 
proline at position 628 in the extracellular domain 
of integrin α3. Polymorphism Phenotyping, ver-
sion 2 (Polyphen-2) suggested that the mutation 
might be damaging; it is not classified as a single-
nucleotide polymorphism. Each variant was not 
found in at least 100 chromosomes from ethni-
cally matched controls.
Consequences of Loss of Integrin α3
The mutation c.1173_1174del led to loss of inte-
grin α3 in the skin, kidneys, and lungs of Patient 
1 (Fig. 4 in the Supplementary Appendix). In vitro, 
lack of integrin α3 was shown on flow-cytometric 
studies of primary keratinocytes, without substan-
tial changes in α2, β1, or α6 integrin subunits 
(Fig. 5 in the Supplementary Appendix). We next 
explored the consequences of this mutation on 
tissue architecture.
The basement membranes in kidney, lung, and 
skin specimens from Patient 1 had profound ab-
normalities, as visualized by collagen IV staining. 
In contrast to the strong, linear staining of nor-
mal basement membranes, the basement mem-
branes in the patient’s kidney and lung had a weak 
and interrupted signal, and the epidermal base-
ment membrane was clearly disorganized (Fig. 2C, 
2D, and 2E).
The distribution of basement-membrane–
associated molecules was altered in the patient’s 
skin. Instead of the normal, linear pattern at the 
dermal–epidermal junction, the laminin α3 chain 
(a component of laminin-332) was detected in blis-
tered areas both at the roof and on the floor of 
the split (Fig. 2F) and in nonblistered areas be-
low the plane of the basement membrane. Simi-
larly, collagen VII was widely distributed in the 
upper dermis together with increased tenascin C 
and fibronectin (Fig. 6 in the Supplementary Ap-
pendix). The hemidesmosomal integrin α6β4 
showed interrupted staining, whereas β1 integrin 
appeared to be unchanged (Fig. 7 in the Supple-
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mentary Appendix). These observations clearly 
indicate that loss of integrin α3 impairs not only 
epidermal adhesion but also basement-mem-
brane assembly and remodeling.
Discussion
The ITGA3 mutations in the three patients we de-
scribe were associated with a complex phenotype 
comprising congenital nephrotic syndrome, inter-
stitial lung disease, and epidermolysis bullosa. 
The deletion mutation, which abolished integrin 
α3, and the splice-site and missense mutations all 
led to similar clinical features. Both full knockout 
mouse models11,14 and organ-specific α3 knock-
out models12,13,16,17 support this conclusion.
Integrin α3 knockout mice have defects in kid-
ney and lung organogenesis and skin fragility, 
and they die within 24 hours after birth.11,14 Ab-
normal nephrogenesis, disorganized and widened 
glomerular basement membranes, and the absence 
of podocyte foot processes11 support the roles of 
integrin α3 during development, as well as in 
organization of the extracellular matrix, modu-
lation of the actin cytoskeleton, and cell shape.3 
Podocyte-specific integrin α3 knockout mice have 
massive postnatal proteinuria,12 as seen in our 
patients.
In the three patients, the lung findings were 
surprising and were not predicted by the animal 
models.11,13 In contrast to the severe clinical course 
and abnormal imaging findings, routine staining 
of lung-biopsy samples showed nonspecific chang-
es. We speculate that the observed lung disease 
probably reflects the consequences of the basic 
genetic defect, since respiratory distress began in 
the first days of life, when severe abnormalities 
were already evident on chest radiography. De-
fects in bronchial development, as described in 
the integrin α3 knockout mouse model, were not 
documented. Surprisingly, mice with specific loss 
of integrin α3 in lung epithelial cells have no ab-
normalities of the alveolar architecture or respira-
tory function, but integrin α3 has been identified 
as a critical regulator of epithelial–mesenchymal 
transition and tissue remodeling in response to 
injury.13 We speculate that perturbed morpho-
genesis and abnormal functioning of the blood–
air barrier accounted for reduced gas diffusion, 
resulting in respiratory failure in our patients.
Skin was mildly affected in our patients. Blis-
ters and erosions began at the age of 2 to 
4 months. Disorganization of the basement mem-
brane diminished dermal–epidermal adhesion, 
and on exposure to external shearing stress, the 
basement membrane ruptured and blisters arose. 
The anomalies that are caused by loss of integrin 
α3 are unique and represent a new form of epider-
molysis bullosa. In the context of the complex 
disorder, reepithelialization of the wounds was 
somewhat delayed in Patient 1, in contrast to the 
faster wound healing reported in keratinocyte-
specific knockout mice.16,17
These three children with integrin α3 mutations 
had multiorgan involvement and survived the neo-
natal period. It is possible that the loss of integrin 
α3 has additional direct consequences (e.g., the in-
volvement of the nervous system, since in the 
integrin α3 knockout mice the architecture of the 
cerebral cortex was perturbed, probably because 
of abnormal neuron–glia interactions during de-
velopment).21,22
Taken together, this phenotype, consisting of 
congenital nephrotic syndrome, interstitial lung 
disease, and epidermolysis bullosa, reflects the 
developmental and postnatal pleiotropic functions 
of integrin α3, showing that this integrin is in-
dispensable for basement-membrane organization. 
Figure 2 (facing page). Identification and Consequences 
of the ITGA3 Deletion in Patient 1.
In Panel A, immunofluorescence (green) staining of a 
skin specimen with the monoclonal integrin α3 antibody 
P1B5 shows loss of expression; a skin specimen from a 
control subject is shown for comparison. The position 
of the epidermal basement membrane is indicated by 
the white dashed line; nuclei are blue. In Panel B, chro-
matograms show the partial sequences of ITGA3. The 
homozygous mutation c.1173_1174del (arrow) leads to 
frameshift and formation of a premature termination 
codon, p.Pro392ValfsX2. Immunohistochemical and im-
munofluorescence staining of collagen IV is shown in 
biopsy specimens of kidney (Panel C), lung (Panel D), 
and skin (Panel E) obtained from Patient 1 and age-
matched controls. In Panel C, the marked areas in the 
images on the left side are shown at higher magnifica-
tion on the right side; the arrows indicate the glomeru-
lar basement membrane and Bowman’s capsule base-
ment membrane. In addition, there is a loss of lateral 
cell junctions in the patient. In Panel D, arrows point to 
the basement membranes, which are very thin in the 
specimen from the patient. Panel E shows irregularly 
distributed collagen IV below the basement membrane 
(dashed white line) in the patient’s skin. Panel F shows 
immunofluorescence staining of the laminin α3 chain, a 
ligand of integrin α3. In the patient’s skin, laminin α3 ap-
pears at the blister (asterisk) roof and base (arrows).
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The exquisite interdependence between the struc-
tural assembly of basement membranes and the 
modulation of the cytoskeleton in vivo is pivotal 
for adequate barrier functions in the kidney, lung, 
and skin. In contrast to in vitro systems, in which 
compensatory mechanisms have been described,17 
these functions are insufficient in vivo.
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